BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7665138)

  • 1. [Present status and task the in study of pathophysiologic mechanism of latent herpes simplex virus infection and the viral re-activation].
    Minagawa H
    Fukuoka Igaku Zasshi; 1995 Jul; 86(7):299-303. PubMed ID: 7665138
    [No Abstract]   [Full Text] [Related]  

  • 2. Viral, neuronal and immune factors which may influence herpes simplex virus (HSV) latency and reactivation.
    Fraser NW; Valyi-Nagy T
    Microb Pathog; 1993 Aug; 15(2):83-91. PubMed ID: 8255209
    [No Abstract]   [Full Text] [Related]  

  • 3. Chromatin control of herpes simplex virus lytic and latent infection.
    Knipe DM; Cliffe A
    Nat Rev Microbiol; 2008 Mar; 6(3):211-21. PubMed ID: 18264117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity to latent viral infection: many skirmishes but few fatalities.
    Khanna KM; Lepisto AJ; Hendricks RL
    Trends Immunol; 2004 May; 25(5):230-4. PubMed ID: 15099562
    [No Abstract]   [Full Text] [Related]  

  • 5. [Topics on herpes simplex virus pathogenesis--roles of viral 'non-essential' genes and host immune status].
    Minagawa H
    Uirusu; 2002 Jun; 52(1):109-15. PubMed ID: 12227158
    [No Abstract]   [Full Text] [Related]  

  • 6. [Herpes simplex virus: mechanism of latency and reactivation phases].
    Boulinguez S; Rogez S
    Ann Dermatol Venereol; 1997; 124(5):409-15. PubMed ID: 9739902
    [No Abstract]   [Full Text] [Related]  

  • 7. Repression of viral transcription during herpes simplex virus latency.
    Preston CM
    J Gen Virol; 2000 Jan; 81(Pt 1):1-19. PubMed ID: 10640537
    [No Abstract]   [Full Text] [Related]  

  • 8. An inquiry into the molecular basis of HSV latency and reactivation.
    Roizman B; Whitley RJ
    Annu Rev Microbiol; 2013; 67():355-74. PubMed ID: 24024635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cycle of human herpes simplex virus infection: virus transport and immune control.
    Cunningham AL; Diefenbach RJ; Miranda-Saksena M; Bosnjak L; Kim M; Jones C; Douglas MW
    J Infect Dis; 2006 Sep; 194 Suppl 1():S11-8. PubMed ID: 16921466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intradermal doxorubicin reduces ganglionic reactivation of latent herpes simplex virus in mice after pretreatment with hypertonic saline.
    Sekizawa T; Openshaw H; Itoyama Y
    J Med Virol; 2003 Jun; 70(2):263-6. PubMed ID: 12696114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of cellular death signals in the reactivation of herpes simplex virus type 1 and lambda bacteriophage from a latent state.
    Panet A; Braun E; Honigman A; Steiner I
    J Theor Biol; 2005 Sep; 236(1):88-94. PubMed ID: 15967186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity in latent Herpes simplex virus infection.
    Bystrická M; Russ G
    Acta Virol; 2005; 49(3):159-67. PubMed ID: 16178513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus and varicella-zoster virus: why do these human alphaherpesviruses behave so differently from one another?
    Mori I; Nishiyama Y
    Rev Med Virol; 2005; 15(6):393-406. PubMed ID: 16173110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of herpes simplex virus shedding and infection in the oral cavity of seropositive patients undergoing head and neck radiation therapy.
    Epstein JB; Gorsky M; Hancock P; Peters N; Sherlock CH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Dec; 94(6):712-6. PubMed ID: 12464896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress-associated immunomodulation and herpes simplex virus infections.
    Sainz B; Loutsch JM; Marquart ME; Hill JM
    Med Hypotheses; 2001 Mar; 56(3):348-56. PubMed ID: 11359358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo.
    Sawtell NM; Thompson RL; Stanberry LR; Bernstein DI
    J Infect Dis; 2001 Oct; 184(8):964-71. PubMed ID: 11574910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus latency: molecular aspects.
    Ho DY
    Prog Med Virol; 1992; 39():76-115. PubMed ID: 1317601
    [No Abstract]   [Full Text] [Related]  

  • 18. [Herpes simplex virus infection: host-virus interaction].
    Rozenberg F
    Pathol Biol (Paris); 2002 Aug; 50(7):414-8. PubMed ID: 12360693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus gene expression in neurons: viral DNA synthesis is a critical regulatory event in the branch point between the lytic and latent pathways.
    Nichol PF; Chang JY; Johnson EM; Olivo PD
    J Virol; 1996 Aug; 70(8):5476-86. PubMed ID: 8764059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards an understanding of the molecular basis of herpes simplex virus latency.
    Efstathiou S; Preston CM
    Virus Res; 2005 Aug; 111(2):108-19. PubMed ID: 15951043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.